The access should fit the operation
Smaller incision.
Complete decision.


Your Incision Should Be Your Decision™
Minimally invasive heart surgery second opinion
A cardiac surgeon and cardiologist independently review your complete record—then compare conventional open, mini-sternotomy, mini-thoracotomy, robotic, and catheter-based approaches in the context of your anatomy, procedure, risk, durability, and lifetime plan.
No referral or travel required. Live physician consultation is optional and costs extra.
The access should fit the operation

A smaller incision is an access strategy—not a substitute for a complete, durable operation.
Explore a sample reportFour different routes
Patients are often asked to compare labels that are not equivalent. A useful second opinion identifies what happens inside the heart, how the team gets there, and what could be gained or compromised by that access.
A midline breastbone incision can provide broad exposure and flexibility. That may matter for complex anatomy, multiple procedures, redo operations, or an unexpected finding that must be addressed safely.
Often considered when access, complexity, or combined work matters more than incision length.Selected valve, aortic, coronary, or rhythm procedures may be performed through a smaller partial sternotomy or an incision between the ribs. The operation inside the heart may be similar even though the route is different.
Candidacy depends on anatomy, procedure scope, prior operations, vascular access, and the team’s experience.Robotic systems can extend a surgeon’s reach through ports and a small working incision. They may be used for selected mitral, coronary, or other procedures at centers with the right team and infrastructure.
Robotic access is a technique—not proof that it is the safest or most durable option for a particular case.Some valve or structural-heart problems can be treated through blood vessels without a surgical chest incision. TAVR and transcatheter mitral therapies solve different problems and have anatomy- and durability-specific tradeoffs.
Age, anatomy, surgical risk, coronary access, future procedures, device durability, and lifetime strategy all belong in the comparison.Candidacy is patient-specific
The right question is not simply, “Can this be done minimally invasively?” It is, “Can this approach accomplish the entire operation safely, completely, and durably for this patient?”
Aortic-valve replacement, mitral repair, bypass surgery, AFib surgery, and combined operations require different access, instruments, and contingency plans. “Minimally invasive” is not one procedure.
Valve structure, coronary targets, chest shape, aortic calcification, peripheral vessels, prior grafts, and the location of disease may expand—or narrow—the technically reasonable approaches.
A small incision may be attractive for an isolated problem. Significant coronary, valve, aortic, or rhythm disease that should be addressed together can change the balance.
Previous sternotomy, chest radiation, bypass grafts, devices, infection, or prior catheter procedures can affect access, adhesions, cannulation, and the value of a different route.
Kidney, lung, vascular, neurologic, frailty, bleeding, and recovery factors may matter more than incision length. Validated models help, but they do not capture every procedural detail.
The safest operation is not defined by a marketing label. Procedure-specific volume, outcomes, the whole operating team, rescue capability, and honest conversion planning belong in the decision.
Procedure examples
A valve, a bypass target, and atrial fibrillation do not create the same technical problem. The report keeps the underlying treatment decision separate from the route used to perform it.
Selected aortic-valve procedures may use a partial sternotomy or right thoracotomy; TAVR is a separate catheter-based strategy. Selected mitral repairs may be performed through a right thoracotomy or robotically. Repairability, concomitant disease, age, and lifetime planning matter.
Selected patients may be considered for minimally invasive direct coronary bypass, robot-assisted grafting, or hybrid treatment. Number and location of coronary targets, conduit strategy, completeness of revascularization, and emergency access matter.
A Maze or other surgical ablation may be performed with open surgery, through limited access, or in selected stand-alone or hybrid programs. Rhythm history, atrial anatomy, valve disease, stroke prevention, and the complete operation should be considered together.
A smaller incision may be less important than treating every clinically meaningful problem in one durable plan. The report makes visible when an isolated approach may leave another valve, coronary, aortic, or rhythm question unresolved.

WHITEGLOVE Heart Team
The cardiac surgeon focuses on exposure, procedure completeness, conversion, durability, and technical fit. The cardiologist places those questions alongside imaging, medical therapy, catheter-based alternatives, coronary disease, and the lifetime plan.
Meet the entire WHITEGLOVE Heart TeamWHITEGLOVE Insights™
The report is written for patients and families, but grounded in the source record, current evidence, and two physician reviews.
Download a sample report
The diagnosis, symptoms documented in the record, prior treatment, proposed operation, and why a second approach is being considered—clearly source-linked.
The valve, coronary, aortic, vascular, chest, and prior-surgery details that may affect access and what must be accomplished.
Conventional open, mini-sternotomy, mini-thoracotomy, robotic, and catheter-based paths are compared only where they plausibly fit the documented case.
Incision, visualization, completeness, bypass strategy, conversion risk, recovery, durability, reintervention, and follow-up are explained in patient-facing language.
The underlying indication for treatment is separated from the question of access, with relevant guideline categories and clinical variables made visible.
Validated risk models are considered alongside anatomy, frailty, prior surgery, vascular access, organ function, and procedure-specific limitations.
Absent source imaging, incomplete coronary or vascular evaluation, missing operative details, and other gaps become useful questions for the treating team.
Procedure-specific experience, public outcomes when available, geography, conversion capability, and practical fit are placed in front of you.
If you add a live consultation, the questions you ask and the Heart Team’s explanation can be preserved in plain language.
A concise list of records, questions, consultations, or transfer conversations to discuss with the physicians responsible for your care.
Six questions worth asking
A second opinion should make uncertainty useful. These are not reasons to accept or reject an approach; they are the questions that help a treating team explain why it fits.
Will the proposed approach address every important valve, coronary, aortic, or rhythm problem—or only the easiest one to reach through the smaller access?
A smaller incision has value only if the planned repair, replacement, grafting, or ablation is technically sound and appropriate for the patient’s lifetime strategy.
A careful plan includes the circumstances in which the team would enlarge the incision or convert to sternotomy and how quickly that can happen if safety requires it.
Incision size is one factor. Procedure duration, bypass time, lung function, pain control, mobility, complications, support at home, and the operation itself also shape recovery.
Ask how often the surgeon and complete team perform this exact procedure through this exact approach—not simply whether the hospital advertises “minimally invasive” care.
Future coronary access, valve-in-valve possibilities, reoperation, device durability, anticoagulation, surveillance, and age can matter more than the first recovery alone.
Evidence, with its limits visible
Guidelines, modeled estimates, and program-level outcomes describe populations and available inputs. They do not predict an individual result, prove candidacy for a particular approach, or replace physician judgment.
How it works
The 24-hour written-review clock starts after the records and imaging required for the case have been received and confirmed complete—not when a request is first submitted.
Tell a Heart Team specialist what operation and approach were proposed and which part of the decision feels unresolved. No referral or records are needed for the first conversation.
Upload what you have or authorize the records team to help obtain the source imaging, reports, clinical notes, laboratories, and proposed operative plan.
A cardiac surgeon and cardiologist examine the same complete record from different clinical perspectives, then confer.
Your WHITEGLOVE Insights™ report is delivered within 24 hours after the records and imaging required for the review are complete.
Start with the written review
The written Heart Team review is direct pay and starts at $495. A live consultation is optional and costs extra. WHITEGLOVEMD does not submit an insurance claim.
Independent review by a cardiac surgeon and cardiologist, physician conference, and one co-signed patient-facing report.
Add a live consultation if speaking directly with a reviewing physician would help. See current package details before purchasing.
Minimally invasive heart surgery FAQ
The term generally describes heart surgery performed without a full median sternotomy, but it covers very different techniques. Surgical examples include partial sternotomy, mini-thoracotomy, port-access, and robotic approaches. Catheter-based treatments are separate, non-surgical comparators. The operation being performed—not merely the incision—determines whether two paths are truly comparable.
Candidacy depends on the exact procedure, valve or coronary anatomy, aorta and peripheral vessels, chest anatomy, prior surgery or radiation, other disease that may need treatment, overall risk, and the experience of the proposed team. A complete-record review can organize those factors, but the treating physicians make the procedural decision.
Not automatically. A smaller incision may offer recovery or comfort advantages in selected patients, but safety also depends on exposure, completeness of treatment, procedure and bypass time, vascular access, conversion planning, the patient’s risk factors, and the team’s experience. The most appropriate access is case-specific.
Robotic surgery is one minimally invasive technique. The surgeon controls the instruments from a console while the operation is performed through ports and a small working incision. Other minimally invasive operations do not use a robot, and many catheter-based procedures are performed by a different route entirely.
Selected surgical aortic-valve replacements can be performed through a partial sternotomy or right thoracotomy. TAVR is a separate catheter-based option. The reasonable comparison depends on age, anatomy, surgical risk, coronary access, durability, other required surgery, and lifetime valve strategy.
Selected mitral repairs can be performed through a right mini-thoracotomy or with robotic assistance at experienced centers. Whether that route is reasonable depends on repair complexity, valve and coronary findings, vascular access, prior operations, other procedures that may be needed, and the program’s results with that exact approach.
Some patients may be considered for minimally invasive direct coronary bypass, robot-assisted coronary surgery, or a hybrid approach combining bypass and catheter treatment. Coronary target location, number of vessels, conduit plan, completeness of revascularization, emergency access, and program experience are central to the comparison.
Selected surgical ablation procedures may be performed through limited incisions, thoracoscopically, or in hybrid programs. The relevant choice depends on AFib history, atrial anatomy, valve disease, stroke-prevention needs, prior ablation, and whether another heart operation is planned.
No. Incision size can influence pain and mobility, but the operation itself, bypass time, lung function, complications, rehabilitation, frailty, and support at home also affect recovery. Claims about recovery should be tied to the exact procedure and patient, not the label alone.
Conversion is sometimes the safest response to limited exposure, bleeding, unexpected anatomy, or another intraoperative problem. A useful preoperative conversation should include the team’s reasons for conversion, its experience managing it, and whether immediate full access is available.
A cardiac surgeon and cardiologist independently review the same complete record, confer, and co-sign one WHITEGLOVE Insights™ report. The written review begins at $495. A live physician consultation is optional and costs extra.
The written report is delivered within 24 hours after the records and imaging required for the review have been received and confirmed complete. Time spent requesting or transferring records is outside that 24-hour window.
WHITEGLOVEMD is a direct-pay educational decision-support and independent medical-record review service. The written Heart Team review starts at $495, and WHITEGLOVEMD does not submit an insurance claim. Live consultation is optional and costs extra.
No. WHITEGLOVEMD provides educational decision support and independent medical-record review. It does not diagnose, prescribe, select a procedure, or replace the treating physicians. The report helps patients and families ask better questions and discuss reasonable options with the clinicians responsible for their care.
Do not delay urgent or time-sensitive treatment while waiting for WHITEGLOVEMD. New or worsening chest pain, severe shortness of breath, fainting, stroke symptoms, or other possible emergency symptoms require immediate emergency evaluation; call 911.
The decision stays yours
Start with a complimentary orientation or begin the two-physician written review from $495.